BRAINSWAY LTD

NASDAQ: BWAY (Brainsway Ltd.)

Kemas kini terakhir: 2 jam lalu

8.78

-0.20 (-2.23%)

Penutupan Terdahulu 8.98
Jumlah Dagangan 66,955
Harga / Pendapatan (P/E Ke hadapan) 12.15
Harga / Jualan (P/S) 5.62
Harga / Buku (P/B) 4.62
Julat 52 Minggu
7.14 (-18%) — 17.40 (98%)
Margin Keuntungan 9.01%
Margin Operasi (TTM) 4.99%
EPS Cair (TTM) 0.220
Pertumbuhan Hasil Suku Tahunan (YOY) 26.80%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 897.30%
Jumlah Hutang/Ekuiti (D/E MRQ) 8.73%
Nisbah Semasa (MRQ) 5.03
Aliran Tunai Operasi (OCF TTM) 12.13 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 3.66 M
Pulangan Atas Aset (ROA TTM) 1.42%
Pulangan Atas Ekuiti (ROE TTM) 7.41%

AISkor Stockmoo

0.4
Harga rendah berbanding pertumbuhan perolehannya. info
Pulangan di bawah kos modalnya. Pulangan atas modal meningkat. info
Hutang rendah. Keuntungan lemah. Kecairan jangka pendek mencukupi. Aliran tunai positif. info
Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info NA
Pertumbuhan Tersirat info NA
Sejarah Penilaian info NA
Nilai Pegangan info NA
Premium Risiko info NA
Penilaian Pasaran info NA
Aliran menaik sepanjang tahun lalu. Jauh di bawah paras tertinggi 52 minggu. info
Aliran menurun: harga di bawah purata bergeraknya, dan purata itu sedang menurun. Harga telah jatuh jauh di bawah purata itu. Dagangan lebih tinggi pada hari harga turun. info
Daripada analisis teknikal AI kami terhadap carta. info NA
Corak Lilin info NA
Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info
Berita terkini kebanyakannya positif. info
Sentimen Pegangan info NA
Institusi bersih +0.96% daripada saham dalam pemfailan 13F terkini: 32 pemegang menambah, 27 mengurang (suku berakhir 30 Sep 2026). info
Kedudukan jual singkat -4.2% dari 31 Aug hingga 30 Oct 2026, 2.5 hari untuk tutup (FINRA). info
Aktiviti Orang Dalam info NA
Persekitaran pasaran berhati-hati. info
Sektor ketinggalan berbanding pasaran.
Tonggak-tonggak tidak sependapat, jadi skor dilemahkan.
Di bawah garis aliran jangka sederhana. info
Harga rendah berbanding purata 52 minggunya. Naik dalam tempoh 5 tahun. info
Aliran turun bagi ketiga-tiga tempoh. Momentum jangka pendek menurun. info
Tiada isyarat jelas daripada sokongan dan rintangan. info
Skor Akhir 0.40
Tunjuk semua

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Devices (US) Bercampur Bercampur
Medical Devices (Global) Bercampur Bercampur
Stok Brainsway Ltd. Bercampur Menurun

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B Skor
BWAY - - - 4.62 0.4
SSII - - - 6.11 -2.0
QTI - - - 9.14 -5.0
AXGN - - - 6.12 0.0
ESTA - - - 128.59 -1.7
NMTC - - - 1.80 -0.3

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Sektor Healthcare
Industri Medical Devices
Gaya Pelaburan Small Growth
% Dimiliki oleh Orang Dalam 6.40%
% Dimiliki oleh Institusi 32.27%

Pemilikan

Nama Tarikh Syer Dipegang
Valor Management Llc 30 Sep 2026 5,314,950
Masters Capital Management Llc 30 Sep 2026 1,246,099
Essex Investment Management Co Llc 30 Sep 2026 574,818
Cresset Asset Management, Llc 30 Sep 2026 314,924
Hwg Holdings Lp 30 Sep 2026 253,050
Y.D. More Investments Ltd 30 Sep 2026 224,382
Eagle Global Advisors Llc 30 Sep 2026 182,606
Legato Capital Management Llc 30 Sep 2026 176,569
Ark Investment Management Llc 30 Sep 2026 146,850
Sei Investments Co 30 Sep 2026 119,717
Walleye Capital Llc 30 Sep 2026 106,834

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Institusi

Pemilikan institusi: 28.39%

Kedudukan Pemegang Saham
Bertambah 32 715,233
Berkurang 27 782,187
Baharu 20 567,025
Dijual habis 8 116,475

Pemfailan SEC 13F melalui Nasdaq, pemfailan terkini hingga 30 Sep 2026. Pemfailan tiba sehingga 45 hari selepas setiap suku.

Kedudukan Jual Singkat

Penyelesaian Saham Hari untuk tutup
30 Oct 2026 199,353 2.5
15 Oct 2026 226,033 1.7
30 Sep 2026 250,485 2.8
15 Sep 2026 199,566 2.2
31 Aug 2026 208,111 2.5
14 Aug 2026 156,367 1.0

Data jual singkat FINRA melalui Nasdaq, dilaporkan dua kali sebulan.

4 Positif 0 Negatif 0 Neutral
Tarikh Jenis Butiran
10 Nov 2026 Yahoo Finance BrainsWay Ltd (BRSYF) (Q3 2026) Earnings Call Highlights: Revenue Jumps 34% as Margins Expand ...
BrainsWay Ltd (BRSYF) posted $18.1 million in Q3 2026 revenue, doubled operating income to $2.6 million, and signaled full-year results at the high end of guidance on strong SWIFT and OCD demand.
10 Nov 2026 Yahoo Finance What Brainsway (BWAY) Said on Its Q3 Earnings Call
Brainsway (NASDAQ:BWAY) reported 34% revenue growth and a more than doubling of operating income in the third quarter of 2026, as shipments of its Deep TMS systems increased and reimbursement coverage expanded for its accelerated treatment protocol. The company expects full-year results to land at…
10 Nov 2026 Yahoo Finance BrainsWay Reports Third Quarter 2026 Financial Results and Operational Highlights
Revenue increased 34% to $18.1 million in Q3 2026; Operating income rose 107% to $2.6 million and Adjusted EBITDA rose approximately 92% to $3.9 million Remaining performance obligations grew 31% year-over-year to approximately $85 million Shipped 130 Deep TMS systems in Q3 2026, a 44% increase…
02 Nov 2026 Yahoo Finance BrainsWay Announces Strategic Collaboration with Mindful Health Solutions
Latest Collaboration Comes Amid Progress in Other Strategic Initiatives, Including Follow-on Investment in Earlier Minority Stake Investment TargetBURLINGTON, Mass. and JERUSALEM, Nov. 02, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader…
28 Oct 2026 Yahoo Finance BrainsWay to Report Third Quarter 2026 Financial Results on November 10, 2026
BURLINGTON, Mass. and JERUSALEM, Oct. 28, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced non-invasive neurostimulation treatments for mental health disorders, today announced that it will report its third quarter 2026…
26 Oct 2026 Yahoo Finance BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
BURLINGTON, Mass. and JERUSALEM, Oct. 26, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced further expansion in the number of medical policies across the U.S.…
19 Oct 2026 Yahoo Finance BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group
Partnership with Established Southern California Behavioral Health Provider Aims to Accelerate Innovative Application of Interventional Psychiatry TreatmentsBURLINGTON, Mass. and JERUSALEM, Oct. 19, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a…
13 Oct 2026 Yahoo Finance BrainsWay Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered Lives
BURLINGTON, Mass. and JERUSALEM, Oct. 13, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced further expansion in the number of medical policies across the U.S.…
10 Sep 2026 Yahoo Finance BrainsWay’s (BWAY) Growth Streak Just Got Harder To Ignore
On August 12, BrainsWay Ltd. (NASDAQ:BWAY) reported second-quarter 2026 results that make the neurostimulation company look less like a niche medtech story and more like a genuine growth compounder. Revenue climbed 35% year over year to a record $17.1 million, and adjusted EBITDA more than doubled…
09 Sep 2026 Yahoo Finance Are Options Traders Betting on a Big Move in Brainsway Stock?
Investors need to pay close attention to BWAY stock based on the movements in the options market lately.
08 Sep 2026 Yahoo Finance BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™
Peer-reviewed pilot study shows 83.3% response rate and 50% remission rate in depressive symptoms, alongside measurable neurophysiological changes in brain activity and connectivity BURLINGTON, Mass. and JERUSALEM, Sept. 08, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY), a global…
27 Aug 2026 Yahoo Finance Wall Street Analysts See a 30.07% Upside in Brainsway (BWAY): Can the Stock Really Move This High?
The mean of analysts' price targets for Brainsway (BWAY) points to a 30.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
27 Aug 2026 Yahoo Finance BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation
Peer-reviewed secondary analysis adds to growing body of clinical evidence supporting the potential role of Deep TMS in addressing suicidal ideation among patients with major depressive disorderBURLINGTON, Mass. and JERUSALEM, Aug. 27, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY)…
Papar semua

Isyarat Terkini corak lilin dan silang EMA

▼ Silang maut 16 sesi lalu · 27 Oct
Jangka panjang · EMA 50/200
EMA 50 hari melintas ke bawah EMA 200 hari, tanda yang diperhatikan ramai bahawa arah aliran jangka panjang telah berubah menurun.

Persediaan Teknikal Sederhana

Susunan aliran
Kecerunan
Kemasukan –
Dagangan
Aliran menurun: harga di bawah purata bergeraknya, dan purata itu sedang menurun. Harga telah jatuh jauh di bawah purata itu. Dagangan lebih tinggi pada hari harga turun.
Rintangan terdekat: 10.33 – 10.67 · paras sederhana

AI Analisis Teknikal

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda